Cite This Page
Bibliographic details for Improved Tactical Linked to Community Tumor Reply Subsequent Multisite Radiotherapy as well as Pembrolizumab Second Analysis of a Period I Test
- Page name: Improved Tactical Linked to Community Tumor Reply Subsequent Multisite Radiotherapy as well as Pembrolizumab Second Analysis of a Period I Test
- Author: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors
- Publisher: OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, .
- Date of last revision: 6 January 2024 08:06 UTC
- Date retrieved: 1 June 2024 15:53 UTC
- Permanent URL: https://news.npo.digital/index.php?title=Improved_Tactical_Linked_to_Community_Tumor_Reply_Subsequent_Multisite_Radiotherapy_as_well_as_Pembrolizumab_Second_Analysis_of_a_Period_I_Test&oldid=438235
- Page Version ID: 438235
Citation styles for Improved Tactical Linked to Community Tumor Reply Subsequent Multisite Radiotherapy as well as Pembrolizumab Second Analysis of a Period I Test
APA style
Improved Tactical Linked to Community Tumor Reply Subsequent Multisite Radiotherapy as well as Pembrolizumab Second Analysis of a Period I Test. (2024, January 6). OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . Retrieved 15:53, June 1, 2024 from https://news.npo.digital/index.php?title=Improved_Tactical_Linked_to_Community_Tumor_Reply_Subsequent_Multisite_Radiotherapy_as_well_as_Pembrolizumab_Second_Analysis_of_a_Period_I_Test&oldid=438235.
MLA style
"Improved Tactical Linked to Community Tumor Reply Subsequent Multisite Radiotherapy as well as Pembrolizumab Second Analysis of a Period I Test." OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, . 6 Jan 2024, 08:06 UTC. 1 Jun 2024, 15:53 <https://news.npo.digital/index.php?title=Improved_Tactical_Linked_to_Community_Tumor_Reply_Subsequent_Multisite_Radiotherapy_as_well_as_Pembrolizumab_Second_Analysis_of_a_Period_I_Test&oldid=438235>.
MHRA style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, 'Improved Tactical Linked to Community Tumor Reply Subsequent Multisite Radiotherapy as well as Pembrolizumab Second Analysis of a Period I Test', OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , 6 January 2024, 08:06 UTC, <https://news.npo.digital/index.php?title=Improved_Tactical_Linked_to_Community_Tumor_Reply_Subsequent_Multisite_Radiotherapy_as_well_as_Pembrolizumab_Second_Analysis_of_a_Period_I_Test&oldid=438235> [accessed 1 June 2024]
Chicago style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors, "Improved Tactical Linked to Community Tumor Reply Subsequent Multisite Radiotherapy as well as Pembrolizumab Second Analysis of a Period I Test," OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, , https://news.npo.digital/index.php?title=Improved_Tactical_Linked_to_Community_Tumor_Reply_Subsequent_Multisite_Radiotherapy_as_well_as_Pembrolizumab_Second_Analysis_of_a_Period_I_Test&oldid=438235 (accessed June 1, 2024).
CBE/CSE style
OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK contributors. Improved Tactical Linked to Community Tumor Reply Subsequent Multisite Radiotherapy as well as Pembrolizumab Second Analysis of a Period I Test [Internet]. OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK, ; 2024 Jan 6, 08:06 UTC [cited 2024 Jun 1]. Available from: https://news.npo.digital/index.php?title=Improved_Tactical_Linked_to_Community_Tumor_Reply_Subsequent_Multisite_Radiotherapy_as_well_as_Pembrolizumab_Second_Analysis_of_a_Period_I_Test&oldid=438235.
Bluebook style
Improved Tactical Linked to Community Tumor Reply Subsequent Multisite Radiotherapy as well as Pembrolizumab Second Analysis of a Period I Test, https://news.npo.digital/index.php?title=Improved_Tactical_Linked_to_Community_Tumor_Reply_Subsequent_Multisite_Radiotherapy_as_well_as_Pembrolizumab_Second_Analysis_of_a_Period_I_Test&oldid=438235 (last visited June 1, 2024).
BibTeX entry
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Improved Tactical Linked to Community Tumor Reply Subsequent Multisite Radiotherapy as well as Pembrolizumab Second Analysis of a Period I Test --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "https://news.npo.digital/index.php?title=Improved_Tactical_Linked_to_Community_Tumor_Reply_Subsequent_Multisite_Radiotherapy_as_well_as_Pembrolizumab_Second_Analysis_of_a_Period_I_Test&oldid=438235", note = "[Online; accessed 1-June-2024]" }
When using the LaTeX package url (\usepackage{url}
somewhere in the preamble) which tends to give much more nicely formatted web addresses, the following may be preferred:
@misc{ wiki:xxx, author = "OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK", title = "Improved Tactical Linked to Community Tumor Reply Subsequent Multisite Radiotherapy as well as Pembrolizumab Second Analysis of a Period I Test --- OPENN - EUROPESE OMROEP - OFFICIAL PUBLIC EUROPEAN NETHERLANDS NETWORK{,} ", year = "2024", url = "\url{https://news.npo.digital/index.php?title=Improved_Tactical_Linked_to_Community_Tumor_Reply_Subsequent_Multisite_Radiotherapy_as_well_as_Pembrolizumab_Second_Analysis_of_a_Period_I_Test&oldid=438235}", note = "[Online; accessed 1-June-2024]" }